NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death
Summary: Gastric cancer (GC) is a deadly malignancy that demands effective therapeutic intervention capitalizing unique drug target/s. Here, we report that indomethacin, a cyclooxygenase non-selective non-steroidal anti-inflammatory drug, arrests GC cell growth by targeting mitochondrial deacetylase...
Main Authors: | Subhashis Debsharma, Saikat Pramanik, Samik Bindu, Somnath Mazumder, Troyee Das, Uttam Pal, Debanjan Saha, Rudranil De, Shiladitya Nag, Chinmoy Banerjee, Nakul Chandra Maiti, Zhumur Ghosh, Uday Bandyopadhyay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224006059 |
Similar Items
-
Plasmodium falciparum Alba6 exhibits DNase activity and participates in stress response
by: Shiladitya Nag, et al.
Published: (2024-04-01) -
Nuclease activity of Plasmodium falciparum Alba family protein PfAlba3
by: Chinmoy Banerjee, et al.
Published: (2023-04-01) -
Defense Surveillance System at the Interface: Response of Rice Towards Rhizoctonia solani During Sheath Blight Infection
by: Udita Acharya, et al.
Published: (2022-12-01) -
Allergy to NSAIDs
by: Paola Toche Pinaud
Published: (2010-10-01) -
NSAID enteropathy
by: E. N. Kareva
Published: (2020-02-01)